IL141166A0 - New compounds - Google Patents

New compounds

Info

Publication number
IL141166A0
IL141166A0 IL14116699A IL14116699A IL141166A0 IL 141166 A0 IL141166 A0 IL 141166A0 IL 14116699 A IL14116699 A IL 14116699A IL 14116699 A IL14116699 A IL 14116699A IL 141166 A0 IL141166 A0 IL 141166A0
Authority
IL
Israel
Prior art keywords
new compounds
compounds
new
Prior art date
Application number
IL14116699A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL141166A0 publication Critical patent/IL141166A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL14116699A 1998-08-21 1999-08-18 New compounds IL141166A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802794A SE9802794D0 (sv) 1998-08-21 1998-08-21 New compounds
PCT/SE1999/001402 WO2000011000A2 (en) 1998-08-21 1999-08-18 New compounds

Publications (1)

Publication Number Publication Date
IL141166A0 true IL141166A0 (en) 2002-02-10

Family

ID=20412307

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14116699A IL141166A0 (en) 1998-08-21 1999-08-18 New compounds

Country Status (20)

Country Link
US (3) US6579884B1 (es)
EP (2) EP1411056A3 (es)
JP (1) JP2002523415A (es)
KR (1) KR20010072798A (es)
CN (1) CN1329613A (es)
AR (1) AR020226A1 (es)
AT (1) ATE280768T1 (es)
AU (1) AU5767999A (es)
BR (1) BR9913103A (es)
CA (1) CA2339286A1 (es)
DE (1) DE69921483T2 (es)
DK (1) DK1105391T3 (es)
ES (1) ES2229763T3 (es)
IL (1) IL141166A0 (es)
NO (1) NO20010860L (es)
PT (1) PT1105391E (es)
SE (1) SE9802794D0 (es)
SI (1) SI1105391T1 (es)
WO (1) WO2000011000A2 (es)
ZA (1) ZA200100913B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
TWI351405B (en) * 2002-09-19 2011-11-01 Schering Corp Novel imidazopyridines as cyclin dependent kinase
MY136840A (en) * 2002-09-19 2008-11-28 Schering Corp Pyrazolopyridines as cyclin dependent kinase inhibitors
CA2503290C (en) 2003-03-10 2012-12-04 Altana Pharma Ag Novel process for the preparation of roflumilast
SE0301904D0 (sv) 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
US8536492B2 (en) * 2003-10-27 2013-09-17 Applied Materials, Inc. Processing multilayer semiconductors with multiple heat sources
CN1874772A (zh) 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2-a]吡啶衍生物
WO2005070927A2 (en) * 2004-01-26 2005-08-04 Altana Pharma Ag 1,2,4-triazolo[1,5-a] pyridines as gastric acid secretion inhibitors
KR102152809B1 (ko) * 2004-07-28 2020-09-07 다케다 야쿠힌 고교 가부시키가이샤 피롤로〔2,3-c〕피리딘 화합물, 그 제조 방법 및 용도
CA2601250C (en) * 2005-03-16 2014-10-28 Nycomed Gmbh Taste masked dosage form containing roflumilast
WO2008065199A1 (en) * 2006-12-01 2008-06-05 Galapagos N.V. Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases
US20100267712A1 (en) * 2007-09-27 2010-10-21 The United States of America, as represented by the Secretary, Department of Health and Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
EP2452680B1 (en) 2009-07-09 2019-12-18 RaQualia Pharma Inc. Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility
CN111606846A (zh) * 2020-05-12 2020-09-01 广州理文科技有限公司 一种n`-三氟甲磺酰基n杂芳香胺类化合物及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
US5574042A (en) 1992-11-02 1996-11-12 Fujisawa Pharmaceutical Co., Ltd Imidazo [1,2-a] pyridines and their pharmaceutical use
IL108520A (en) 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE209647T1 (de) 1993-04-22 2001-12-15 Byk Gulden Lomberg Chem Fab Pyridiniumsalze und ihre verwendung zur bekämpfung von helicobacter-bakterien
UA48122C2 (uk) 1993-10-11 2002-08-15 Бік Гульден Ломберг Хеміше Фабрік Гмбх АЛКОКСІАЛКІЛКАРБАМАТИ ІМІДАЗО[1,2-а]ПІРИДИНІВ, СПОСІБ ЇХ ОДЕРЖАННЯ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
EP0773945A1 (de) 1994-07-28 1997-05-21 Byk Gulden Lomberg Chemische Fabrik GmbH Acylimidazopyridine
WO1996003403A1 (de) 1994-07-28 1996-02-08 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzylimidazopyridine
WO1996003402A1 (de) 1994-07-28 1996-02-08 Byk Gulden Lomberg Chemische Fabrik Gmbh Halogenimidazopyridine
SK197A3 (en) 1994-07-28 1997-06-04 Byk Gulden Lomberg Chem Fab Imidazopyridine-azolidinones, preparation method thereof, pharmaceutical composition containing same and their use
DE19602853A1 (de) 1996-01-26 1997-07-31 Byk Gulden Lomberg Chem Fab Neue Halogenimidazopyridine
DE59712297D1 (de) 1996-01-26 2005-06-09 Altana Pharma Ag 3-alkylimidazopyridine
SE9700661D0 (sv) * 1997-02-25 1997-02-25 Astra Ab New compounds
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE9802793D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds

Also Published As

Publication number Publication date
ATE280768T1 (de) 2004-11-15
DE69921483D1 (de) 2004-12-02
ES2229763T3 (es) 2005-04-16
SE9802794D0 (sv) 1998-08-21
ZA200100913B (en) 2002-05-02
US20050154007A1 (en) 2005-07-14
US6579884B1 (en) 2003-06-17
WO2000011000A3 (en) 2000-06-15
NO20010860L (no) 2001-04-23
NO20010860D0 (no) 2001-02-20
WO2000011000A2 (en) 2000-03-02
CN1329613A (zh) 2002-01-02
BR9913103A (pt) 2001-05-08
CA2339286A1 (en) 2000-03-02
EP1105391B1 (en) 2004-10-27
PT1105391E (pt) 2005-01-31
AU5767999A (en) 2000-03-14
JP2002523415A (ja) 2002-07-30
DK1105391T3 (da) 2005-01-24
EP1411056A3 (en) 2004-04-28
SI1105391T1 (en) 2005-02-28
US20030220364A1 (en) 2003-11-27
US6790960B2 (en) 2004-09-14
EP1411056A2 (en) 2004-04-21
DE69921483T2 (de) 2006-02-02
KR20010072798A (ko) 2001-07-31
AR020226A1 (es) 2002-05-02
EP1105391A2 (en) 2001-06-13

Similar Documents

Publication Publication Date Title
GB9804734D0 (en) Compounds
GB9804175D0 (en) Compounds
IL141166A0 (en) New compounds
GB9826941D0 (en) Compounds
GB9818689D0 (en) Compounds
GB9818881D0 (en) Compounds
GB9821977D0 (en) Compounds
GB9809823D0 (en) Compounds
GB9810876D0 (en) Compounds
GB9812522D0 (en) Compounds
GB9801712D0 (en) Compounds
HUP0101446A3 (en) New compounds
GB9809217D0 (en) Compounds
GB9822140D0 (en) Compounds
GB9825383D0 (en) Compounds
GB9803611D0 (en) Compounds
GB9805447D0 (en) Compounds
GB9806379D0 (en) Compounds
GB9806690D0 (en) Compounds
GB9806699D0 (en) Compounds
GB9806701D0 (en) Compounds
GB9816990D0 (en) Compounds
GB9805133D0 (en) Compounds
GB9808813D0 (en) Compounds
GB9805132D0 (en) Compounds